Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy F T Arnsten

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
The Journal of Pediatrics|July 3, 2010
The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association CortexAmy F T Arnsten
Nature Reviews. Neuroscience|May 21, 2009
Stress signalling pathways that impair prefrontal cortex structure and functionAmy F T Arnsten
CNS Drugs|July 23, 2009
Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunctionAmy F T Arnsten
The Journal of Clinical Psychiatry|September 12, 2006
Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathwaysAmy F T Arnsten
Biological Psychiatry|April 15, 2011
Catecholamine influences on dorsolateral prefrontal cortical networksAmy F T Arnsten
Cerebral Cortex (New York, N.Y. : 1991)|April 17, 2007
Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illnessAmy F T Arnsten
Neuroscience|October 27, 2018
A Closer Look: Electron Microscopic Insights into Aging Glutamate Synapses in the Prefrontal Association CortexAmy F T Arnsten
Neurobiology of Learning and Memory|October 19, 2020
Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across speciesAmy F T Arnsten
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|February 25, 2011
Prefrontal cortical network connections: key site of vulnerability in stress and schizophreniaAmy F T Arnsten
Psychopharmacology|June 19, 2004
Adrenergic targets for the treatment of cognitive deficits in schizophreniaAmy F T Arnsten
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
The Journal of Pediatrics|July 3, 2010
The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association CortexAmy F T Arnsten
Nature Reviews. Neuroscience|May 21, 2009
Stress signalling pathways that impair prefrontal cortex structure and functionAmy F T Arnsten
CNS Drugs|July 23, 2009
Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunctionAmy F T Arnsten
The Journal of Clinical Psychiatry|September 12, 2006
Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathwaysAmy F T Arnsten
Biological Psychiatry|April 15, 2011
Catecholamine influences on dorsolateral prefrontal cortical networksAmy F T Arnsten
Cerebral Cortex (New York, N.Y. : 1991)|April 17, 2007
Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illnessAmy F T Arnsten
Neuroscience|October 27, 2018
A Closer Look: Electron Microscopic Insights into Aging Glutamate Synapses in the Prefrontal Association CortexAmy F T Arnsten
Neurobiology of Learning and Memory|October 19, 2020
Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across speciesAmy F T Arnsten
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|February 25, 2011
Prefrontal cortical network connections: key site of vulnerability in stress and schizophreniaAmy F T Arnsten
Psychopharmacology|June 19, 2004
Adrenergic targets for the treatment of cognitive deficits in schizophreniaAmy F T Arnsten
Pageof 16